Track C1: Value-Based Health Practices for Population Health Outcomes and Sustainable Health
Saturday, 27 September | 13:30–15:00 | Riverfront Ballroom (Level 2)
As healthcare systems worldwide transition from volume-driven to value-based models, the role of pharmacy practice is evolving beyond traditional medication dispensing to one of strategic decision-making, population-health stewardship, and care optimisation.
This breakout session explores how value-based health practices can transform patient care and pharmaceutical care to improve outcomes, reduce low-value interventions, and contribute to a more sustainable health system. Through a series of thought-provoking talks and interactive discussions, expert speakers will examine critical levers of change, from evidence-informed population health decision-making to health system redesign for efficient, patient-centred service delivery.
Participants will gain insights into operationalising value-based principles in practice, understand the challenges and opportunities in aligning services with population health objectives, and engage in discussions on policy, practice, and innovation that will shape the future of sustainable healthcare delivery.
Presentations
Prescribing Value, Delivering Impact: Value-Based Care for a Sustainable Health System by Dr Albert TY
This session explores how health systems can adopt an appropriate and value-based care (AVBC) mindset – anchored on clinical appropriateness, outcomes that matter to patients, and the prudent use of resources – to truly optimise population health.
We’ll unpack three critical pillars:
• Doing it: Learn how to operationalise AVBC through standardisation of care, intelligent use of data, and cross-sectoral alignment.
• Measuring it: What indicators reflect true value? Learn how to move beyond activity-based metrics to outcomes-based frameworks that incorporate quality and cost.
• Sustaining it: From culture change to incentive design, explore what it takes to embed AVBC into the DNA of a health system.
Drawing on Singapore’s evolving experience and international insights, this talk will make the case that AVBC is not just project – it is a system-wide mindset.
Decision-Making For Medications and Pharmaceuticals – Delivering High-Value Care While Ensuring Cost-Effective Use of Medications by Mr Darren NG
Text
• Bullet
Collaborating with Multidisciplinary Stakeholders to Develop and Implement Value-Based Healthcare Strategies by Ms Winnie KOH
This presentation examines the paradigm shift from volume-based to value-based care (VBC) in Singapore’s healthcare system, with localised examples on practice transformation. The discussion explores Singapore’s innovative capitation model and its impact on healthcare delivery.
We’ll examine real-world case studies demonstrating improved patient outcomes and cost-effectiveness and how pharmacists can contribute significantly to VBC through medication therapy management and patient engagement. The session will highlight practical examples of patient-reported outcome measures specific to medication adherence, including the validated Beliefs about Medications Questionnaire and the DOSE Non-Adherence Score. Through real-world cases, we will demonstrate how these tools can be integrated into pharmacy practice to improve patient outcomes.
Attendees will gain practical insights into implementing VBC principles within their practice settings, contributing to Singapore’s healthcare transformation journey.
Speakers
Dr Albert TY
Director
Value, Safety and Performance Division
Ministry of Health
Singapore
Dr Albert Ty’s work in the Ministry of Health (MOH) is focused on driving the development and implementation of national policies, frameworks, or processes aimed at promoting a culture of appropriate and value-based care, patient safety, high reliability, and continuous quality improvement in Singapore healthcare institutions. Prior to this, Dr Ty had extensive public health leadership experience in the MOH, including work on health promotion strategies, non-communicable disease epidemiology and control, public health intelligence, and specialist training and assessments.
Mr Darren NG
Senior Assistant Director
Health Technology Evaluation,
Utilisation Review and Adoption
Agency for Care Effectiveness
Singapore
Mr Darren Ng is currently Senior Assistant Director (Health Technology Evaluation, Utilisation Review and Adoption) at the Agency for Care Effectiveness (ACE), Ministry of Health (MOH) Singapore. He leads a team to drive the adoption of appropriate, clinically effective, and cost-effective drugs and medical technologies in Singapore’s public hospitals and institutions (PHIs). His team also serves as the secretariat steering the MOH National Pharmacy & Therapeutics Committee in advocating and promoting appropriate use of drugs in PHIs.
In his time with ACE, Mr Ng had co-authored the National Medicines Policy and worked closely with a diverse range of policy makers and stakeholders in the development and implementation of various national policies and initiatives such as the National Drug Formulary, the Healthier SG white paper, and the MediShield Life Cancer Drug List. A pharmacist by training, Mr Ng is passionate about partnering with stakeholders in translating HTA into actual clinical practice and unlocking value for patients.
Ms Winnie KOH
Deputy Director
Clinical & Academic Development
National Healthcare Group
Singapore
Ms Winnie Koh serves as Deputy Director at National Healthcare Group, Singapore, where she works across professional teams to develop and implement value-based care strategies. With experience spanning different roles in Singapore’s public healthcare sector, she has contributed to various healthcare transformation initiatives.
Her expertise in healthcare data analytics was demonstrated through leading the development of the inaugural business intelligence system of Tan Tock Seng Hospital (TTSH), which successfully integrated over 25 source systems to enhance data-driven decision-making. A notable achievement in her career was pioneering workforce transformation through job redesign initiatives at TTSH. She led efforts to enhance the capabilities of Patient Service Associates, making TTSH the first restructured hospital in Singapore to successfully empower non-clinical staff to perform selected clinical procedures. This innovative approach has helped optimise healthcare resources while creating meaningful career progression opportunities for frontline staff.
